J&J, Janssen Win Mass. Risperdal Suit On Teen's Weight Gain
Johnson & Johnson and its subsidiary Janssen Pharmaceuticals Inc. on Wednesday prevailed over claims in Massachusetts federal court saying their antipsychotic drug Risperdal caused a Bay State man to gain excessive...To view the full article, register now.
Already a subscriber? Click here to view full article